Insuficiencia cardíaca: epidemiología, mecanismos etiopatogénicos y clasificación

A. Leandro Barros , M.C. Monedero Martín , J. Serpa Morán , C. Tejada González , A. Ruiz-Saavedra , A. García Lledó
{"title":"Insuficiencia cardíaca: epidemiología, mecanismos etiopatogénicos y clasificación","authors":"A. Leandro Barros ,&nbsp;M.C. Monedero Martín ,&nbsp;J. Serpa Morán ,&nbsp;C. Tejada González ,&nbsp;A. Ruiz-Saavedra ,&nbsp;A. García Lledó","doi":"10.1016/j.med.2025.06.010","DOIUrl":null,"url":null,"abstract":"<div><div>Heart failure (HF) is a syndrome characterized by the presence of signs and symptoms of systemic/pulmonary congestion and/or low output. Its prevalence is increasing and it has a high mortality rate. It may be due to multiple cardiac and some extracardiac conditions. The key elements for diagnosis are the medical history, physical examination, natriuretic peptides determination, and echocardiogram. Knowing the left ventricular ejection fraction is essential, since it defines groups with different etiopathogenesis, management, and prognosis. Activation and maintenance of the neurohormonal axis is the main trigger for disease progression in HF. In addition, there is ventricular remodeling as an adaptation to volume or pressure overload, either by heart chamber dilation or by ventricular hypertrophy. Treatment aimed at the cause and neurohormonal axis blockade is key to management and has prognostic implications in patients with HF with reduced ejection fraction.</div></div>","PeriodicalId":100912,"journal":{"name":"Medicine - Programa de Formación Médica Continuada Acreditado","volume":"14 35","pages":"Pages 2105-2113"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine - Programa de Formación Médica Continuada Acreditado","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304541225001532","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Heart failure (HF) is a syndrome characterized by the presence of signs and symptoms of systemic/pulmonary congestion and/or low output. Its prevalence is increasing and it has a high mortality rate. It may be due to multiple cardiac and some extracardiac conditions. The key elements for diagnosis are the medical history, physical examination, natriuretic peptides determination, and echocardiogram. Knowing the left ventricular ejection fraction is essential, since it defines groups with different etiopathogenesis, management, and prognosis. Activation and maintenance of the neurohormonal axis is the main trigger for disease progression in HF. In addition, there is ventricular remodeling as an adaptation to volume or pressure overload, either by heart chamber dilation or by ventricular hypertrophy. Treatment aimed at the cause and neurohormonal axis blockade is key to management and has prognostic implications in patients with HF with reduced ejection fraction.
心力衰竭:流行病学、病因机制和分类
心力衰竭(HF)是一种以全身/肺部充血和/或低输出量体征和症状为特征的综合征。它的流行率正在上升,死亡率很高。这可能是由于多种心脏和一些心脏外的条件。诊断的关键要素是病史、体格检查、利钠肽测定和超声心动图。了解左心室射血分数是必要的,因为它可以区分不同病因、治疗和预后的人群。神经激素轴的激活和维持是心衰疾病进展的主要触发因素。此外,心室重构是对容量或压力过载的适应,通过心室扩张或心室肥厚。针对病因和神经激素轴阻断的治疗是治疗的关键,对射血分数降低的心衰患者具有预后意义。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.30
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信